Rigorously tested and continuously validated in practice, Cytel software is used at thousands of pharmaceutical, biotech, medical device companies, and leading independent research institutes.
Cytel’s cutting-edge trial design and implementation expertise, with a specialty in adaptive trials, is helping sponsor companies of all sizes to increase success rates in clinical development.
Cytel Broadens Clinical Trial Services with New Waltham, MA, Office
Cytel opens a new office in Waltham, MA, The additional space is required to support the company’s rapidly expanding Clinical Research Services.
Just Published in Nature Journal
Cyrus Mehta, Cytel president and co-founder, co-authored new paper on emerging Efficacy-to-Effectiveness trials in Nature's Clinical Pharmacology & Therapeutics.
Adaptive Trial Short Course, April 25 at Harvard School of Public Health
Learn adaptive sample size re-estimation designs from Cytel's Cyrus Mehta and Charles Liu. Workshop attendees receive a free 90-day trial of new East® 6.2. Registration is fast and affordable.
What Clients Say
Simona Skerjanec, VP Medical Science
The Medicines Company
Steven B. Ketchum, VP Research and Development
Joe Heyes, VP
Early Stage Biostatistics Merck
Dr. Scott Harris, CMO
Dr. Patrice Rioux, VP, CMO